Sinopharm offers to take Hong Kong-listed China-TCM private

A consortium led by state-owned Sinopharm has revived a take-private bid for China-TCM, the Hong-Kong-listed drug maker said on Wednesday, valuing it at US$2.96 billion.

Related Keywords

Hong Kong , China , Chinese , Xinyao Wang , , Hong Kong Listed , Haier Electronic , Tcm , Traditional Chinese Medicine , Inopharm , China Traditional Chinese Medicine Holdings , Hina Tcm , Drugmaker ,